The anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events among overweight people who have cardiovascular disease, whether or not they also have heart failure, according ...
Aug 22, 2024
0
39
A study by Michigan State University found that non-deceptive placebos, or placebos given to people fully knowing they are placebos, effectively manage stress—even when the placebos are administered remotely.
Aug 16, 2024
0
24
Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, according to a new study led ...
Sep 3, 2024
0
5
In a small pilot study, UNC School of Medicine researchers led by Flavio Frohlich, Ph.D., used a new closed-loop system to measure the electrical brain patterns of individual patients and then stimulate those patterns with ...
Aug 27, 2024
0
25
Finerenone reduced the composite of total first and recurrent heart failure (HF) events (hospitalizations for HF or urgent HF visits) and cardiovascular death in patients with HF and mildly reduced or preserved ejection fraction, ...
Sep 2, 2024
0
0
The humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand, Lu AG09222, is better than placebo for reducing migraine frequency over four weeks, according to a ...
Sep 5, 2024
0
0
The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global ...
Sep 2, 2024
0
0
The association of prenatal ω-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) with the risk for childhood atopic dermatitis (AD) varies based on the maternal cyclooxygenase-1 (COX1) genotype, according to a study published ...
Sep 4, 2024
0
0
The epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-free survival compared to placebo without any significant new adverse reactions, according to data from the POLESTAR ...
9 hours ago
0
0
